Overview

A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting

Status:
Completed
Trial end date:
2017-12-19
Target enrollment:
Participant gender:
Summary
A Pharmacokinetics study of Baraclude in a real world clinical setting in Japan.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Entecavir